25.06.2025

Proacta signs new contract in the field of digital medicine – agreement with the Institute of Physiology and Pathology of Hearing

Proacta SA, operating in a consortium with Euvic SA (leader), is implementing another project in the area of digital transformation of healthcare. The company has received a mutually signed agreement with the Institute of Physiology and Pathology of Hearing based in Warsaw. The project involves the development and implementation of a central IT system supporting diagnostic and therapeutic processes in the field of audiology and genetics.

Project objective
The system being developed aims to integrate audiometric and genetic data of patients with hearing loss. It includes both hardware components and advanced software modules, including user interfaces, classification modules, functional tests, clinical decision support tools, and training and post-implementation services. The solution is designed to optimize diagnostics and provide a personalized therapeutic approach in the field of otolaryngology and clinical genetics.

Significance for Proacta SA
The agreement is valid until March 31, 2026, and its maximum value is PLN 4,907,700.00 gross. Proacta S.A.'s share in the consortium's remuneration is 98%. Payments will be made in stages, in accordance with the implementation schedule.

The project strengthens Proacta's position in the segment of modern IT systems for healthcare, using advanced medical data integration and supporting clinical decisions with the use of AI and classification models, which is in line with the company's long-term strategy for the development of data-driven and AI-based tools for the medical sector.